natgillin/translations-raw huggingface dataset:
At a dose of memantine of 20 mg per day the CSF levels match the ki-value (ki = inhibition constant) of memantine, which is 0.5 µmol in human frontal cortex. 
Pri dozi od 20 mg memantina dnevno, razine u CSL-u odgovaraju ki-vrijednosti (ki = konstanta inhibicije) memantina koja u frontalnom korteksu kod ljudi iznosi 0,5 µmol.
One pump actuation contains 5mg memantine hydrochloride. 
Jedan potisak pumpice sadrži 5 mg memantinklorida.
For removing the screw cap from the bottle the cap must be turned anticlockwise and unscrewed completely (fig.1). 
Za uklanjanje zatvarača s navojem s boce, zatvarač se mora okrenuti u smjeru suprotnom od kazaljke na satu i potpuno odvrnuti (sl.1).
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR BLISTER PACK 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA BLISTER
In patients with mildly impaired renal function (creatinine clearance 50 - 80 ml/min) no dose adjustment is required. 
Kod bolesnika s blagim oštećenjem funkcije bubrežne funkcije (klirens kreatinina 50-80 ml/min) nije potrebna prilagodba doze.
Week 2 (day 8-14): Take one 10 mg tablet once a day (pale yellow to yellow, oval shaped) for 7 days. 
2. tjedan (8. - 14. dan): Uzimajte jednu tabletu od 10 mg jednom dnevno (blijedožutu do žutu, ovalnog oblika) tijekom 7 dana.
Discontinuation of memantine should be considered when evidence of a therapeutic effect is no longer present or if the patient does not tolerate treatment. 
Kada više ne postoji dokaz terapijskog učinka ili ako bolesnik ne podnosi liječenje, treba razmotriti prekid liječenja memantinom.
Administration of Memantine Merz in patients with severe hepatic impairment is not recommended. 
Ne preporučuje se primjena Memantine Merza kod bolesnika s teškim oštećenjem jetrene funkcije.
Memantine Merz film-coated tablets are available in blister packs of 14 tablets, 28 tablets, 30 tablets, 42 tablets, 50 tablets, 56 tablets, 98 tablets, 100 tablets, 112 tablets and multipscks of 840 (20 packs of 42) tablets, 980 (10 packs of 98) tablets or 1000 (20 packs of 50) tablets. 
Memantine Merz filmom obložene tablete dostupne su u pakiranjima s blisterima od 14 tableta, 28 tableta, 30 tableta, 42 tablete, 50 tableta, 56 tableta, 98 tableta, 100 tableta, 112 tableta; i višestrukim pakiranjima od 840 (20 pakiranja od 42) tableta, 980 (10 pakiranja od 98) tableta ili 1000 (20 pakiranja od 50) tableta.
The recommended dose of Memantine Merz for adults and older people is 20 mg once a day. 
Preporučena doza Memantine Merza za odrasle i starije osobe je 20 mg jednom dnevno.
Women taking memantine should not breast-feed. 
Žene koje uzimaju memantin ne bi trebale dojiti.
In order to reduce the risk of side effects this dose is achieved gradually by the following daily treatment scheme. 
Kako bi se smanjio rizik od nuspojava, ta doza se postiže postupno, pridržavajući se sheme dnevnog liječenja.
Women taking Memantine Merz should not breast-feed. 
Žene koje uzimaju Memantine Merz ne smiju dojiti.
Potassium sorbate Sorbitol E 420 
6.1 Popis pomoćnih tvari kalijev sorbat sorbitol E420
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine),as your doctor may need to adjust the dose of your medicine. 
Ako ste nedavno promijenili, ili namjeravate značajno promijeniti svoj način prehrane (npr. s normalne prehrane na strogu vegetarijansku prehranu), ili ako bolujete od stanja renalne tubularne acidoze (RTA - izrazito povećana količina tvari koje tvore kiseline u krvi zbog poremećaja rada bubrega (slaba funkcija bubrega)) ili teških infekcija mokraćnog trakta (struktura kroz koje prolazi mokraća), trebali bi obavijestiti svog liječnika jer će Vam liječnik možda morati prilagoditi dozu lijeka.
From Week 4 on: The patient should take two 10 mg film-coated tablets (20 mg) per day. 
Od 4. tjedna nadalje: Bolesnik treba uzimati dvije filmom obložene tablete od 10 mg (20 mg) dnevno.
- amantadine, ketamine, dextromethorphan - dantrolene, baclofen - cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine - hydrochlorothiazide (or any combination with hydrochlorothiazide) - anticholinergics (substances generally used to treat movement disorders or intestinal cramps) - anticonvulsants (substances used to prevent and relieve seizures) - barbiturates (substances generally used to induce sleep) - dopaminergic agonists (substances such as L-dopa, bromocriptine) - neuroleptics (substances used in the treatment of mental disorders) - oral anticoagulants 
- amantadina, ketamina, dekstrometorfana - dantrolena, baklofena - cimetidina, ranitidina, prokainamida, kinidina, kinina, nikotina - hidroklorotiazida (ili bilo koja kombinacija s hidroklorotiazidom)
Clinipharm Co. Ltd Tel: +356 21 43 74 15 
Ltd Tel: +356 21 43 74 15
Week 2 (day 8-14): The patient should take 1 ml solution (10 mg) equivalent to two pump actuations per day for 7 days. 
2. tjedan (8. - 14. dan): Bolesnik treba uzimati 1 ml otopine (10 mg) što odgovara dva potiska pumpice dnevno, tijekom 7 dana.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR 42 TABLETS AS INTERMEDIATE PACK / COMPONENT OF A MULTIPACK (WITHOUT BLUE BOX) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU KUTIJA ZA 42 TABLETE KAO SREDNJE PAKIRANJE/ DIO VIŠESTRUKOG PAKIRANJA (BEZ PLAVOG OKVIRA)
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (10 x 50 ml) WRAPPED IN FOIL (INCLUDING BLUE BOX) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU NALJEPNICA NA VANJSKOM OMOTU VIŠESTRUKIH PAKIRANJA (10 x 50 ml) ZAMOTANIH
EU/1/12/799/010 840 film-coated tablets (20 packs of 42) EU/1/12/799/011 980 film-coated tablets (10 packs of 98) EU/1/12/799/012 1000 film-coated tablets (20 packs of 50) 
EU/1/12/799/010 840 filmom obloženih tableta (20 pakiranja po 42) EU/1/12/799/011 980 filmom obloženih tableta (10 pakiranja po 98) EU/1/12/799/012 1000 filmom obloženih tableta (20 pakiranja po 50)
Take the screw cap off the bottle: The cap must be turned anticlockwise, unscrewed completely and removed (fig. 1). 
Zatvarač se mora okrenuti u smjeru suprotnom od kazaljke na satu, potpuno odvrnuti i ukloniti (sl. 1).
From Week 4 on: The patient should take one 20 mg film-coated tablet per day. 
Od 4. tjedna nadalje: Bolesnik treba uzimati jednu filmom obloženu tabletu od 20 mg dnevno.
Very rare (may affect up to 1 in 10,000 users): • Seizures 
Vrlo rijetko (mogu se javiti u do 1 na 10 000 osoba):
No genotoxicity has been observed following testing of memantine in standard assays. 
Testiranjem memantina u standardnim pokusima nije primijećena genotoksičnost.
Although no causal relationship has been established, close monitoring of prothrombin time or INR is advisable for patients concomitantly treated with oral anticoagulants. 
Iako uzročna povezanost nije utvrđena, preporučljivo je pažljivo praćenje protrombinskog vremena, odnosno
A pivotal monotherapy study in a population of patients suffering from moderate to severe Alzheimer's disease (mini mental state examination (MMSE) total scores at baseline of 3 - 14) included a total of 252 outpatients. 
Alzheimerove bolesti (početne vrijednosti kratkog testa određivanja mentalnog statusa (MMSE; engl. mini mental state examination) bile su 3-14) uključivalo je ukupno 252 ambulantna bolesnika.
In postmarketing experience these events have been reported in patients treated with Memantine Merz. 
Ovi su događaji prijavljeni u postmarketinškom razdoblju kod bolesnika liječenih Memantine Merzom.
one and a half 10 mg tablet week 4 and beyond two 10 mg tablets once a day 
4. tjedan i nadalje dvije tablete od 10 mg jednom dnevno
In patients with severe renal impairment (creatinine clearance 5 - 29 ml/min) daily dose should be 10 mg per day. 
Kod bolesnika s teškim oštećenjem bubrežne funkcije (klirens kreatinina 5-29 ml/min) dnevna doza bi trebala biti 10 mg dnevno.
In patients with severe renal impairment (creatinine clearance 5 - 29 ml/min) daily dose should be 10 mg (1 ml solution, equivalent to two pump actuations) per day. 
Kod bolesnika s teškim oštećenjem bubrebubrežne funkcije (klirens kreatinina 5-29 ml/min) dnevna doza bi trebala biti 10 mg (1 ml otopine, što odgovara dva potiska pumpice) na dan.
Microcrystalline cellulose Croscarmellose sodium Colloidal anhydrous silica Magnesium stearate 
Jezgra tablete celuloza, mikrokristalična karmelozanatrij, umrežena silicijev dioksid, koloidni, bezvodni magnezijev stearat
Week 3 (day 15-21): Take one 15 mg tablet once a day (grey-orange, oval-oblong) for 7 days. 
3. tjedan (15. - 21. dan): Uzimajte jednu tabletu od 15 mg jednom dnevno (sivo-narančastu, duguljasto ovalnu) tijekom 7 dana.
How to store Memantine Merz 
KAKO ČUVATI MEMANTINE MERZ
EXP {MM/YYYY} 
Rok valjanosti{MM/GGGG}
Package leaflet: Information for the user Memantine Merz 20 mg film-coated tablets 
Uputa o lijeku: Informacija za korisnika Memantine Merz 20 mg filmom obložene tablete memantinklorid
The patient should take one 10 mg film-coated tablet per day (pale yellow to yellow, oval shaped) for 7 days. 
Bolesnik treba uzimati jednu filmom obloženu tabletu od 10 mg (blijedožutu do žutu, ovalnog oblika) dnevno tijekom 7 dana.
Adverse reactions are ranked according to system organ class, using the following convention: very common (≥1/10), common (≥1/100 to < 1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to 
Nuspojave su razvrstane prema klasifikaciji organskih sustava, prema sljedećim skupinama učestalosti: vrlo često (≥1/10), često (≥1/100 i <1/10), manje često (≥1/1 000 i <1/100), rijetko (≥1/10
In patients with moderate renal impairment (creatinine clearance 30 - 49 ml/min) daily dose should be 10 mg per day. 
Kod bolesnika s umjerenim oštećenjem bubrežne funkcije (klirens kreatinina 30-49 ml/min), dnevna doza bi trebala biti 10 mg na dan.
Package leaflet: Information for the user Memantine Merz 10 mg film-coated tablets 
Uputa o lijeku: Informacija za korisnika Memantine Merz 10 mg filmom obložene tablete memantinklorid
You should inform your doctor if you have recently changed or intend to change your diet substantially (e.g. from normal diet to strict vegetarian diet) or if you are suffering from states of renal tubulary acidosis (RTA, an excess of acid-forming substances in the blood due to renal dysfunction (poor kidney function)) or severe infections of the urinary tract (structure that carries urine), as your doctor may need to adjust the dose of your medicine. 
Uzimanje hrane i pića s Memantine Merz s hranom i, pićem Ako ste nedavno promijenili, ili namjeravate značajno promijeniti svoj način prehrane (npr. s normalne prehrane na strogu vegetarijansku prehranu), ili ako bolujete od stanja renalne tubularne acidoze (RTA - izrazito povećana količina tvari koje tvore kiseline u krvi zbog poremećaja rada bubrega (slaba funkcija bubrega)) ili teških infekcija mokraćnog trakta (struktura kroz koje prolazi mokraća), trebali bi obavijestiti svog liječnika jer će Vam liječnik možda morati prilagoditi dozu lijeka.
The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171), iron oxide yellow and red (E 172), all in the tablet coating. 
Drugi sastojci su: mikrokristalična celuloza, umrežena karmelozanatrij, koloidni bezvodni silicijev dioksid i magnezijev stearat, sve u jezgri tablete; te hipromeloza, makrogol 400, titanijev dioksid (E171) i žuti željezov oksid, žuti i crveni (E172), sve u ovojnici tablete.
Week 4 (day 22-28): Take one 20 mg tablet per day (grey-red, oval-oblong) for 7 days. 
4. tjedan (22. - 28. dan): Uzimajte jednu tabletu od 20 mg dnevno (sivo-crvenu, duguljasto ovalnu) tijekom 7 dana.
• There may be a possibility of reduced serum level of hydrochlorothiazide (HCT) when memantine is co-administered with HCT or any combination with HCT. 
• Pri istodobnoj primjeni memantina i hidroklorotiazida (HCT-a) ili neke od kombinacija s HCT-om, postoji mogućnost smanjenja serumske koncentracije HCT-a u serumu.
GENERAL CLASSIFICATION FOR SUPPLY 15. 
NAČIN IZDAVANJA LIJEKA 15. UPUTE ZA UPORABU
The other ingredients are microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, and magnesium stearate, all in the tablet core; and hypromellose, macrogol 400, titanium dioxide (E 171) and iron oxide yellow (E 172) all in the tablet coating. 
Drugi sastojci su: mikrokristalična celuloza,umrežena karmelozanatrij, koloidni bezvodni silicijev dioksid i magnezijev stearat, sve u jezgri tablete; te hipromeloza, makrogol 400, titanijev dioksid (E171) i žuti željezov oksid (E172), sve u ovojnici tablete.
Hepatic impairment 
Nepoznato hepatitis
EU/1/12/799/001 14 film-coated tablets EU/1/12/799/002 28 film-coated tablets EU/1/12/799/003 30 film-coated tablets EU/1/12/799/004 42 film-coated tablets EU/1/12/799/005 50 film-coated tablets EU/1/12/799/006 56 film-coated tablets EU/1/12/799/007 98 film-coated tablets EU/1/12/799/008 100 film-coated tablets EU/1/12/799/009 112 film-coated tablets 
EU/1/12/799/001 14 filmom obloženih tableta EU/1/12/799/002 28 filmom obloženih tableta EU/1/12/799/003 30 filmom obloženih tableta EU/1/12/799/004 42 filmom obložene tablete EU/1/12/799/005 50 filmom obloženih tableta EU/1/12/799/006 56 filmom obloženih tableta EU/1/12/799/007 98 filmom obloženih tableta EU/1/12/799/008 100 filmom obloženih tableta EU/1/12/799/009 112 filmom obloženih tableta
Memantine Merz 10 mg tablets 
Memantine Merz 10 mg tablete
20 mg tablets once a day 
4. tjedan i nadalje tableta od 20 mg jednom dnevno
In a study using orally administered 14C-memantine, a mean of 84% of the dose was recovered within 
U ispitivanju u kojem je korišten oralno primijenjen 14C-memantin uklonjeno je prosječno 84% doze unutar 20 dana, a više od 99% izlučeno je putem bubrega.
EU/1/12/799/013 14 film-coated tablets EU/1/12/799/014 28 film-coated tablets EU/1/12/799/015 42 film-coated tablets EU/1/12/799/016 56 film-coated tablets EU/1/12/799/017 98 film-coated tablets EU/1/12/799/019 14 film-coated tablets EU/1/12/799/020 28 film-coated tablets EU/1/12/799/021 42 film-coated tablets EU/1/12/799/022 56 film-coated tablets EU/1/12/799/023 98 film-coated tablets 
EU/1/12/799/013 14 filmom obloženih tableta EU/1/12/799/014 28 filmom obloženih tableta EU/1/12/799/015 42 filmom obložene tablete EU/1/12/799/016 56 filmom obloženih tableta EU/1/12/799/017 98 filmom obloženih tableta EU/1/12/799/019 14 filmom obloženih tableta EU/1/12/799/020 28 filmom obloženih tableta EU/1/12/799/021 42 filmom obložene tablete EU/1/12/799/022 56 filmom obloženih tableta EU/1/12/799/023 98 filmom obloženih tableta
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg film-coated tablets Memantine hydrochloride 
Memantine Merz 5 mg, 10 mg, 15 mg, 20 mg filmom obložene tablete memantinklorid
• Headache, sleepiness, constipation, elevated liver function tests, dizziness, balance disorder, 
• glavobolja, pospanost, zatvor, povišene razine testova jetrene funkcije, omaglica, poremećaji ravnoteže, nedostatak zraka, povišeni krvni tlak i preosjetljivost na lijek
- if you are allergic (hypersensitive) to memantine hydrochloride or any of the other ingredients of Memantine Merz oral solution (listed in section 6). 
- ako ste alergični (preosjetljivi) na memantinklorid ili neki drugi sastojak Memantine Merz oralne otopine (naveden u dijelu 6).
Memantine Merz 20 mg tablets 
Memantine Merz 20 mg tablete
Τηλ. 
Merzom.
Package leaflet: Information for the user Memantine Merz 5 mg/pump actuation, oral solution 
Uputa o lijeku: Informacija za korisnika Memantine Merz 5 mg/potisak, oralna otopina memantinklorid
Colloidal anhydrous silica 
- oralnih antikoagulansa
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (20x 42 TABLETS) WRAPPED IN FOIL (INCLUDING BLUE BOX) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU NALJEPNICA NA VANJSKOM OMOTU VIŠESTRUKIH PAKIRANJA (20 x 42 TABLETE) ZAMOTANIH
Tablet cores for 5/10/15/20 mg film-coated tablets Microcrystalline cellulose Croscarmellose sodium 
Jezgre tableta za 5 mg/10 mg/15 mg/20 mg filmom obložene tablete celuloza, mikrokristalična karmelozanatrij, umrežena silicijev dioksid, koloidni, bezvodni magnezijev stearat
The study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician's interview based impression of change (CIBIC-plus): p=0.025; Alzheimer´s disease cooperative study- activities of daily living (ADCS-ADLsev): p=0.003; severe impairment battery (SIB): p=0.002). 
U 6. mjesecu ispitivanja pokazani su povoljni učinci liječenja memantinom u usporedbi s placebom (analiza opaženih slučajeva za promjene bazirane na dojmu kliničara nakon intervjua (CIBIC-plus; engl. the clinician´s interview based impression of change): p=0,025; kooperativno ispitivanje
OTHER SPECIAL WARNING(S), IF NECESSARY EXPIRY DATE 
DRUGO (A) POSEBNO (A) UPOZORENJE (A) (AKO JE POTREBNO) ROK VALJANOSTI
Each film-coated tablet contains 5 mg of memantine hydrochloride equivalent to 4.15 mg memantine. 
Svaka filmom obložena tableta sadrži 5 mg memantinklorida, što odgovara 4,15 mg memantina.
The recommended maintenance dose is 20 mg (2 ml solution, equivalent to four pump actuations) per day. 
Bolesnik treba uzimati 2 ml otopine (20 mg) što odgovara četiri potiska pumpice dnevno.
Pale yellow to yellow, oval shaped film-coated tablet with breaking line and engravings "1-0" on one side and "M M" on the other side. 
Blijedožuta do žuta filmom obložena tableta ovalnog oblika, s razdjelnom crtom i utisnutim oznakama “1-0” na jednoj strani i “M M” na drugoj strani.
Merz Pharma GmbH + Co. KGaA Eckenheimer Landstr. 
Merz Pharma GmbH + Co.
Memantine Merz 5mg Memantine Merz 10 mg Memantine Merz 15 mg Memantine Merz 20 mg film-coated tablets 
Memantine Merz 5 mg Memantine Merz 10 mg Memantine Merz 15 mg Memantine Merz 20 mg filmom obložene tablete
Do not use Memantine Merz after the expiry date which is stated on the carton and the blister after EXP. 
Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kartonskoj kutiji i blisteru nakon “Rok valjanosti”.
Detailed information on this medicine is available on the website of the European Medicines Agency (EMA) http://www.ema.europa.eu. 
Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske Agencije za lijekove (EMA) http://www.ema.europa.eu.
Maintenance dose The recommended maintenance dose is 20 mg per day. 
Preporučena doza održavanja je 20 mg na dan.
Memantine Merz 5 mg/pump actuation, oral solution memantine hydrochloride 
Memantine Merz 5 mg/potisak, oralna otopina memantinklorid
Each pump actuation delivers 0.5 ml solution which contains 5 mg of memantine hydrochloride which is equivalent to 4.16 mg memantine. 
Svaki potisak pumpice oslobađa 0,5 ml otopine koja sadrži 5 mg memantinklorida, što odgovara 4,16 mg memantina.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER WRAPPER LABEL ON MULTIPACKS (20 x 42 TABLETS, 20 x 50 TABLETS AND 10 x 98 TABLETS) WRAPPED IN FOIL (INCLUDING BLUE BOX) 
PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKIRANJU NALJEPNICA NA VANJSKOM OMOTU VIŠESTRUKIH PAKIRANJA (20 x 42 TABLETA, 20 x 50 TABLETA
Each film-coated tablet contains 15 mg of memantine hydrochloride equivalent to 12.46 mg memantine. 
Svaka filmom obložena tableta sadrži 15 mg memantinklorida, što odgovara 12,46 mg memantina.
Week 2 (day 8-14): The patient should take one 10 mg film-coated tablet (10 mg) per day for 7 days. 
2. tjedan (8. - 14. dan): Bolesnik treba uzimati jednu filmom obloženu tabletu od 10 mg (10 mg) dnevno tijekom 7 dana.
1 g of solution contains 10 mg of memantine hydrochloride equivalent to 8.31 mg memantine. 
1 g otopine sadrži 10 mg memantinklorida, što odgovara 8,31 mg memantina.
Each film-coated tablet contains 20 mg memantine hydrochloride equivalent to 16.62 mg memantine. 
Svaka filmom obložena tableta sadrži 20 mg memantinklorida što odgovara 16,62 mg memantina.
- if you are allergic (hypersensitive) to memantine hydrochloride or any of the other ingredients of Memantine Merz tablets (listed in section 6). 
- ako ste alergični (preosjetljivi) na memantinklorid ili neki drugi sastojak Memantine Merz filmom obloženih tableta (naveden u dijelu 6.).
Week 3 (day 15-21): The patient should take one and a half 10 mg film-coated tablet (15 mg) per day for 7 days. 
3. tjedan (15. - 21. dan): Bolesnik treba uzimati jednu i pol filmom obloženu tabletu od 10 mg (15 mg) dnevno tijekom 7 dana.
Very rare 
Često konstipacija
Week 1 (day 1-7): The patient should take half a 10 mg film-coated tablet (5 mg) per day for 7 days. 
1. tjedan (1. - 7. dan): Bolesnik treba uzimati polovicu filmom obložene tablete od 10 mg (5 mg) dnevno tijekom 7 dana.
Pack sizes of 14, 28, 42, 56, 98 or multipacks containing 840 (20 x 42) film-coated tablets are presented. 
Filmom obložene tablete se nalaze u pakiranjima od 14, 28, 42, 56, 98 ili višestruko pakiranje 840 (20 x 42) tableta.
The 5 mg film-coated tablets are white to off-white, oval-oblong film-coated tablets with imprint ‘5' on one side and imprint ‘MEM' on the other side. 
Filmom obložene tablete od 5 mg su bijele do gotovo bijele, ovalno duguljaste filmom obložene tablete s utisnutom oznakom ‘5' na jednoj strani i ‘MEM' na drugoj strani.
The 15 mg film-coated tablets are orange to grey-orange, oval-oblong film-coated tablets with imprint ‘15' on one side and imprint ‘MEM' on the other side. 
Filmom obložene tablete od 15 mg su narančaste do sivo-narančaste, ovalno duguljaste filmom obložene tablete s utisnutom oznakom ‘15' na jednoj strani i ‘MEM' na drugoj strani.
• Seizures 
• napadaji
The maximum daily dose is 20 mg per day. 
Titriranje doze Maksimalna dnevna doza je 20 mg na dan.
Lot {number} See embossed stamp. 
Broj serije {broj} Vidjeti reljefni otisak.
Memantine Merz 20 mg film-coated tablets are presented as are pale red to grey-red, oval-oblong with imprint ‘20' on one side and imprint ‘MEM' on the other side. 
Memantine Merz 20 mg filmom obložene tablete su blijedocrvene do sivo-crvene, ovalno duguljaste s utisnutom oznakom ‘20' na jednoj strani i ‘MEM' na drugoj strani.
Memantine Merz 5 mg film-coated tablets are presented as white to off-white, oval-oblong with imprint ‘5' on one side and imprint ‘MEM' on the other side. 
Memantine Merz 5 mg filmom obložene tablete su bijele do gotovo bijele, ovalno duguljaste s utisnutom oznakom ‘5' na jednoj strani i ‘MEM' na drugoj strani.
Memantine Merz 15 mg film-coated tablets are presented as orange to grey-orange, oval-oblong with imprint ‘15' on one side and imprint ‘MEM' on the other side. 
Memantine Merz 15 mg filmom obložene tablete su narančaste do sivo-narančaste, ovalno duguljaste s utisnutom oznakom ‘15' na jednoj strani i ‘MEM' na drugoj strani.
The 20 mg film-coated tablets are pale red to grey-red, oval-oblong film-coated tablets with imprint ‘20' on one side and imprint ‘MEM' on the other side. 
Filmom obložene tablete od 20 mg su blijedocrvene do sivo-crvene, ovalno duguljaste filmom obložene tablete s utisnutom oznakom ‘20' na jednoj strani i ‘MEM' na drugoj strani.
Memantine Merz 5 mg/pump actuation, oral solution 
Memantine Merz 5 mg/potisak, oralna otopina
Memantine Merz 15 mg 7 film-coated tablets. 
Memantine Merz 15 mg 7 filmom obloženih tableta.
One pump actuation delivers 0.5 ml solution which contains 5 mg of memantine hydrochloride which is equivalent to 4.16 mg memantine. 
Svaki potisak oslobađa 0,5 ml otopine koja sadrži 5 mg memantinklorida što odgovara 4,16 mg memantina.
two pump actuations. 
2. tjedan dva potiska pumpice
Name and address of the manufacturer(s) responsible for batch release 
Naziv i adresa proizvođača odgovornog(ih) za puštanje serije lijeka u promet Merz Pharma GmbH & Co.
In patients with moderate renal impairment (creatinine clearance 30 - 49 ml/min) daily dose should be 10 mg (1 ml solution, equivalent to two pump actuations). 
30-49 ml/min), dnevna doza bi trebala biti 10 mg (1 ml otopine, što odgovara dva potiska pumpice).
one pump actuation. 
1. tjedan jedan potisak pumpice